Skip to Content

Oxandrolone Pregnancy and Breastfeeding Warnings

Oxandrolone is also known as: Oxandrin

Medically reviewed on June 19, 2017.

Oxandrolone Pregnancy Warnings

Oxandrolone has been assigned to pregnancy category X by the FDA. Anabolic steroid use, particularly during the first trimester of pregnancy, may cause virilization of the external genitalia of the female fetus. Reversible oligospermia may occur after prolonged administration or excessive dosage in male patients. There are no controlled data in human pregnancy. Oxandrolone use is considered contraindicated during pregnancy.

If reversible oligospermia occurs, the anabolic steroid can be discontinued and if restarted, a lower dosage should be utilized.

See references

Oxandrolone Breastfeeding Warnings

There are no data on the excretion of anabolic steroids into human milk. The manufacturer recommends that due to the potential for adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Oxandrin (oxandrolone)." Bio-Tech, Levittown, PA.

References for breastfeeding information

  1. "Product Information. Oxandrin (oxandrolone)." Bio-Tech, Levittown, PA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.